GKOS (Glaukos) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 01, 2026)


GKOS Glaukos Corp GKOS
79 GF Score
Price $137.57
GF Value $135.79
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Glaukos 5-Year Yield-on-Cost %?

Glaukos GKOS -1.57% 79 5-Year Yield-on-Cost % is 0.00 as of Jul. 01, 2026. GuruFocus rates GKOS with a GF Score™ of 79/100 and a GF Value™ of $135.79 (Fairly Valued). The stock has 6 warning signs investors should review. Among 329 Medical Devices & Instruments companies, Glaukos ranks worse than 303951.06% on this metric.

Glaukos's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Glaukos's 5-Year Yield-on-Cost % or its related term are showing as below:



GKOS's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.33
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Glaukos  (NYSE:GKOS) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Glaukos 5-Year Yield-on-Cost % Related Terms


GKOS vs BIO, BRKR, PODD: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, Glaukos's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glaukos 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Glaukos's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Glaukos's 5-Year Yield-on-Cost % falls into.


GKOS
79GF Score
Glaukos Corp GKOS
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Glaukos 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Glaukos is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Glaukos (GKOS) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 01, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Glaukos and its competitors. According to the industry distribution chart, Glaukos ranks #999999 out of 329 companies in the Medical Devices & Instruments industry.
Is Glaukos' 5-Year Yield-on-Cost % too high?
Glaukos' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Glaukos ranks #999999 out of 329 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Glaukos has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Glaukos' 5-Year Yield-on-Cost % compare to BIO and BRKR?
According to the Medical Devices & Instruments industry distribution chart, Glaukos ranks #999999 out of 329 companies for 5-Year Yield-on-Cost %. This places Glaukos in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.33, based on 329 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Glaukos and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glaukos's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glaukos stock overvalued right now?
Based on GuruFocus' analysis, Glaukos (GKOS) is currently considered Fairly Valued. The stock's GF Value™ is $135.79, compared to a current price of $137.57 — trading 1.3% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Glaukos' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Glaukos (GKOS), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Glaukos (GKOS) Overvalued in 2026?

Based on GuruFocus' analysis, Glaukos stock appears to be overvalued. The current stock price of $137.57 is trading 1.3% above its estimated GF Value™ of $135.79. GuruFocus considers Glaukos to be Fairly Valued.

Key valuation signals for GKOS:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $135.79 vs. price of $137.57 (1.3% above fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the GKOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Glaukos Business Description

Other Exchanges 6GJ:Germany
Address One Glaukos Way, Aliso Viejo, CA, USA, 92656
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
79GF Score

Get the complete analysis for GKOS

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$137.57
Price
$135.79
GF Value